Research blog
May 11, 2026 Research use only

PT-141 Research Notes: Scientific Literature, Assay Context, and References

PT-141 research notes covering scientific literature context, assay variables, analytical documentation, and selected references for laboratory audiences only.

Bremelanotide 2D compound structure
Research-use-only scope: This article provides naming and literature context only. It does not provide preparation, dosing, injection, human-use, animal-use, therapeutic, diagnostic, cosmetic, or clinical guidance.

PT-141 and Bremelanotide are names used for the same compound in published records. BioPep USA uses PT-141 as the product and COA label.

Bremelanotide PT-141 2D compound structure
Bremelanotide / PT-141 structure reference. Source: PubChem CID 9941379.

Terminology in the literature

Review articles place PT-141 within the broader melanocortin receptor ligand field. That receptor context is distinct from a commercial lot record. A source can explain the compound name or receptor class, while the COA documents the identified BioPep USA lot.

Verified references

  1. Yuan XC, Tao YX. Ligands for Melanocortin Receptors: Beyond Melanocyte-Stimulating Hormones and Adrenocorticotropin. Biomolecules. 2022. PMID: 36291616. DOI: 10.3390/biom12101407.
  2. Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006. PMID: 16412534. DOI: 10.1016/j.peptides.2005.01.029.
  3. Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Annals of the New York Academy of Sciences. 2003. PMID: 12851303. DOI: 10.1111/j.1749-6632.2003.tb03167.x.

BioPep USA records

Use the PT-141 product page for current catalog details. The PT-141 documentation page identifies the available 10mg lot, reported purity, analysis date, and COA PDF.

Last source review: July 20, 2026.